The study by Wang et al. revealed a novel protein encoded by circASK1 that plays a crucial role in overcoming gefitinib resistance in lung adenocarcinoma by competitively activating apoptosis signal-regulating kinase 1 (ASK1)-dependent apoptosis [206]. This evidence concerns the gene MAP3K5 and lung adenocarcinoma.